Morgan Stanley’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.6K | Sell |
54,577
-117,584
| -68% | -$85.2K | ﹤0.01% | 6432 |
|
|
2025
Q1 | $148K | Sell |
172,161
-221,445
| -56% | -$191K | ﹤0.01% | 5850 |
|
|
2024
Q4 | $661K | Sell |
393,606
-6,882
| -2% | -$11.6K | ﹤0.01% | 5302 |
|
|
2024
Q3 | $1.14M | Buy |
400,488
+78,928
| +25% | +$225K | ﹤0.01% | 4978 |
|
|
2024
Q2 | $752K | Sell |
321,560
-85,031
| -21% | -$199K | ﹤0.01% | 5121 |
|
|
2024
Q1 | $1.2M | Sell |
406,591
-474,941
| -54% | -$1.4M | ﹤0.01% | 4868 |
|
|
2023
Q4 | $2.64M | Buy |
881,532
+478,722
| +119% | +$1.43M | ﹤0.01% | 4773 |
|
|
2023
Q3 | $1.27M | Sell |
402,810
-19,268
| -5% | -$60.9K | ﹤0.01% | 4652 |
|
|
2023
Q2 | $1.63M | Buy |
422,078
+7,896
| +2% | +$30.6K | ﹤0.01% | 4547 |
|
|
2023
Q1 | $1.15M | Buy |
414,182
+42,568
| +11% | +$118K | ﹤0.01% | 4780 |
|
|
2022
Q4 | $669K | Buy |
371,614
+75,359
| +25% | +$136K | ﹤0.01% | 5084 |
|
|
2022
Q3 | $629K | Buy |
296,255
+178,193
| +151% | +$378K | ﹤0.01% | 5146 |
|
|
2022
Q2 | $318K | Buy |
118,062
+66,967
| +131% | +$180K | ﹤0.01% | 5650 |
|
|
2022
Q1 | $222K | Buy |
51,095
+8,664
| +20% | +$37.6K | ﹤0.01% | 5862 |
|
|
2021
Q4 | $221K | Buy |
42,431
+11,675
| +38% | +$60.8K | ﹤0.01% | 6016 |
|
|
2021
Q3 | $189K | Buy |
30,756
+30,256
| +6,051% | +$186K | ﹤0.01% | 6034 |
|
|
2021
Q2 | $5K | Sell |
500
-1,343
| -73% | -$13.4K | ﹤0.01% | 7383 |
|
|
2021
Q1 | $25K | Sell |
1,843
-3,411
| -65% | -$46.3K | ﹤0.01% | 6645 |
|
|
2020
Q4 | $57K | Buy |
5,254
+3,667
| +231% | +$39.8K | ﹤0.01% | 6117 |
|
|
2020
Q3 | $17K | Buy |
+1,587
| New | +$17K | ﹤0.01% | 6117 |
|